Search hospitals > Florida > Orlando
Orlando Health Cancer Institute
Claim this profileOrlando, Florida 32806
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Melanoma
Conducts research for Cancer
Conducts research for Breast cancer
239 reported clinical trials
23 medical researchers
Summary
Orlando Health Cancer Institute is a medical facility located in Orlando, Florida. This center is recognized for care of Breast Cancer, Lung Cancer, Melanoma, Cancer, Breast cancer and other specialties. Orlando Health Cancer Institute is involved with conducting 239 clinical trials across 373 conditions. There are 23 research doctors associated with this hospital, such as Amy Smith, MD, Sajeve S. Thomas, Jennifer Tseng, MD, and Omar R. Kayaleh.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Amy Smith, MDArnold Palmer Hospital for Children8 years of reported clinical research
Expert in Brain Tumor
Expert in Cancer
54 reported clinical trials
107 drugs studied
Sajeve S. ThomasOrlando Health Cancer Institute8 years of reported clinical research
Expert in Melanoma
Studies Skin Cancer
20 reported clinical trials
32 drugs studied
Jennifer Tseng, MDOrlando Health Cancer Institute11 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
30 drugs studied
Omar R. KayalehOrlando Health Cancer Institute6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
6 reported clinical trials
23 drugs studied
Clinical Trials running at Orlando Health Cancer Institute
Lung Cancer
Breast Cancer
Skin Cancer
Melanoma
Bladder Cancer
Ovarian Cancer
Bladder Carcinoma
Kidney Cancer
Prostate Cancer
Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Orlando Health Cancer Institute?
Orlando Health Cancer Institute is a medical facility located in Orlando, Florida. This center is recognized for care of Breast Cancer, Lung Cancer, Melanoma, Cancer, Breast cancer and other specialties. Orlando Health Cancer Institute is involved with conducting 239 clinical trials across 373 conditions. There are 23 research doctors associated with this hospital, such as Amy Smith, MD, Sajeve S. Thomas, Jennifer Tseng, MD, and Omar R. Kayaleh.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.